ocular myasthenia


Also found in: Wikipedia.

ocular myasthenia

[‚äk·yə·lər ‚mī·əs′thē·nē·ə]
(medicine)
A form of myasthenia gravis that is restricted to the eye muscles, symptoms may include droopy eyelids and blurred or double vision.
References in periodicals archive ?
Our case has been reported as the coexistence of ocular myasthenia gravis and diabetic ketoacidosis at the age of 4 years with the aim of discussing the Type I DM and JMG association.
(5) Up to 40 per cent of people with ocular myasthenia will develop generalised myasthenia.
Pruthvi, "Ocular myasthenia gravis in a setting of thyrotoxicosis," Indian Journal of Endocrinology and Metabolism, vol.
reported a case describing a 19-year-old male patient presenting with symptoms and positive laboratory findings for autoimmune hyperthyroid thyroiditis and ocular myasthenia gravis.
Zhang, "Treatment of 87 cases of ocular myasthenia gravis in children with combination of TCM and Western Medicine," Shaanxi Journal of Traditional Chinese Medicine, 2006.
The study population comprised subjects who were referred to our EMG laboratory to exclude ocular myasthenia between January 2010 and June 2013.
Background: Single-fiber electromyography (SFEMG) abnormality in the extensor digitorum communis (EDC) was reported in ocular myasthenia gravis (OMG), which indicated subclinical involvement beyond extraocular muscles in OMG patients.
To estimate the clinical significance of anti-acetylcholine receptor antibody (anti-AChR-Ab) levels in suspected ocular myasthenia gravis.
Raising awareness of ocular myasthenia is one UK charity's main objective this October.
In our study, we present a patient with ocular myasthenia, Hashimoto's thyroiditis, and iron deficiency anemia who later developed reactive hypoglycemia.
Also discussed by the volume's 18 chapters are neuromuscular junction physiology and pathophysiology; acetylcholine receptor structure; immunopathogenesis of myasthenia gravis; ocular myasthenia; thymona-associated paraneoplastic myasthenia gravis; electrodiagnosis of neuromuscular junction disorders; autoantibody testing in the diagnosis and management of autoimmune disorders of neuromuscular transmission and related diseases; treatment of myasthenia gravis; neurocritical care of myasthenic crisis; thymectomy for non-thyomatous myasthenia gravis; Lambert-Eaton syndrome; acquired neuromyotonia; congenital myasthenic syndromes; toxic neuromuscular transmission disorders; and the impact of myasthenia gravis on mood, cognitive function, and quality of life.